2020
DOI: 10.1007/s00213-020-05717-3
|View full text |Cite
|
Sign up to set email alerts
|

Altered fronto-occipital connectivity during visual selective attention in regular cannabis users

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
18
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 18 publications
(29 citation statements)
references
References 74 publications
1
18
1
Order By: Relevance
“…Also, the small and type of population samples can be related to differences between studies. Some studies have reported a detriment in the executive control system in adolescent cannabis users (Abdullaev et al, 2010, Cengel et al, 2018, but not others (Rangel-Pacheco et al, 2020;Vilar-López et al, 2013), as ours. It could be because our participants had a later cannabis use…”
Section: Discussioncontrasting
confidence: 43%
See 2 more Smart Citations
“…Also, the small and type of population samples can be related to differences between studies. Some studies have reported a detriment in the executive control system in adolescent cannabis users (Abdullaev et al, 2010, Cengel et al, 2018, but not others (Rangel-Pacheco et al, 2020;Vilar-López et al, 2013), as ours. It could be because our participants had a later cannabis use…”
Section: Discussioncontrasting
confidence: 43%
“…It has also been reported that cannabis abstinence for at least 23 days in adolescent cannabis users still presented poorer attention efficiency relative to non-using control adolescents (Medina, Hanson, Schweinsburg, et al, 2007); this effect was negatively related to lifetime cannabis use. Contrasting studies have failed to document cannabisinduced attention impairment (Chang et al, 2006;Indlekofer et al, 2009;Rangel-Pacheco et al, 2020;Scott et al, 2018;Vilar-López et al, 2013). The inconsistency of these results may be due to the type of task used (Colizzi & Bhattacharyya, 2018), the differences among the samples evaluated, such as the frequency of cannabis use, the age at onset, total consumption time, whether the subject has developed cannabis dependence, or the time required for an abstinence period from cannabis.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Unfortunately, hair sample analysis was not available for eight participants from the control group. However, it is important to note that biological measures of drug use (illicit substances or psychotropic medication) is rarely used in nonusing controls in the research field on cannabis (or other illicit drugs) and self-reported measures dominate for CU (Smith et al, 2017;Khajehpour et al, 2019;Rangel-Pacheco et al, 2020) or the urine/hair sample analyses detect cannabis use only (no other illicit drugs nor psychotropic medication) (Yücel et al, 2016;Prashad et al, 2018). That is why we would consider it as an additional value of our study and exclusion of this participants form analyses would make CG too small to obtain reliable results.…”
Section: Strengths and Limitationsmentioning
confidence: 99%
“…This special issue on the use of imaging in drug evaluation brings together studies that provide examples of where imaging has been used to address the challenges outlined above. It includes a number of good examples of the use of imaging to advance understanding of pathophysiology that can be used to guide the development of new treatments, specifically for smoking and cannabis use disorders (Rangel-Pacheco et al 2021;Blest-Hopley et al 2021;Tamburin et al 2021), although the principles they demonstrate apply equally to other conditions. Neurochemical imaging has proved particularly informative for understanding pathophysiology and drug action (McCutcheon et al 2020).…”
mentioning
confidence: 99%